Ito J, Noguchi S, Murakami N, Noguchi A
Surg Gynecol Obstet. 1980 Apr;150(4):539-44.
Of 763 patients with carcinoma of the thyroid who had undergone a primary operation between 1948 and 1970, 705 were observed for more than five years. Included were 545 patients with papillary carcinoma. 123 with follicular carcinoma, 59 with microcancer, 30 with undifferentiated carcinoma and six with medullary carcinoma. The relative survival rate for patients with pure undifferentiated carcinoma one year after operation was 27 per cent and that for those with mixed undifferentiated carcinoma was 24 per cent. For patients with differentiated carcinomas, the most important factors affecting the prognosis were age and sex. The 15 year survival rates for women less than 40 years of age with papillary or follicular carcinoma were 102 and 100 per cent, respectively, while for women more than 40 years with papillary or follicular carcinoma, they were 90 and 84 per cent, respectively. For men more than 40 years of age with papillary carcinoma, the relative survival rate was 67 per cent. The size of the tumor and the types of operation did not affect the prognosis in patients less than 40 years. The presence of chronic thyroiditis also had no effect upon the prognosis. The relative survival rate with tumors up to 99 grams in weight, after 20 years, was almost 100 per cent in women less than 40 years of age, while for women more than 40 years of age the survival rates were 95 per cent with tumors weighing less than 20 grams and 72 per cent with those weighing 20 to 99 grams, an indication that tumor size may affect prognosis in older patients.
在1948年至1970年间接受初次手术的763例甲状腺癌患者中,705例被观察了五年以上。其中包括545例乳头状癌患者、123例滤泡状癌患者、59例微小癌患者、30例未分化癌患者和6例髓样癌患者。单纯未分化癌患者术后一年的相对生存率为27%,混合性未分化癌患者为24%。对于分化型癌患者,影响预后的最重要因素是年龄和性别。年龄小于40岁的乳头状或滤泡状癌女性患者的15年生存率分别为102%和100%,而年龄大于40岁的乳头状或滤泡状癌女性患者的15年生存率分别为90%和84%。年龄大于40岁的乳头状癌男性患者的相对生存率为67%。肿瘤大小和手术方式对年龄小于40岁的患者的预后没有影响。慢性甲状腺炎的存在对预后也没有影响。体重达99克的肿瘤患者,年龄小于40岁的女性20年后的相对生存率几乎为100%,而年龄大于40岁的女性,肿瘤重量小于20克的生存率为95%,肿瘤重量在20至99克之间的生存率为72%,这表明肿瘤大小可能影响老年患者的预后。